Biochemistry, Genetics and Molecular Biology
Age
7%
Apoptosis
50%
Aptitude
7%
Autophagy
7%
Bcl-2
31%
Biogenesis
7%
Candidate Gene
8%
Cell Survival
12%
Comprehension
50%
Cyclin-Dependent Kinase
6%
Degradation
7%
Development
7%
down Regulation
6%
Drug Screening
6%
Dynamics
7%
Experimental Mouse
7%
Extracellular Signal-Regulated Kinases
6%
Functional Genomics
15%
Gene
16%
Gene Expression Profiling
15%
Gene Set Enrichment
7%
Glucose Transporter
50%
GLUT1
50%
Homeostasis
7%
Hyperglycemia
7%
Mitochondrial Biogenesis
14%
Mitochondrial Dynamics
7%
Mitochondrion
21%
Mitophagy
50%
Molecular Clock
7%
Mouse
7%
Multivariate Analysis
7%
Myeloid
50%
Overall Survival
14%
Pediatrics
50%
Phenotype
7%
Phosphoproteomics
50%
Phosphorylation
12%
PI3K/AKT/mTOR Pathway
12%
Poly ADP Ribose Polymerase
8%
Protein
12%
Quality Control
50%
Sample
7%
Senescence
7%
Signal Transduction
8%
Small Interfering RNA
25%
Staging
7%
Staining
21%
Synthesis
7%
Upregulation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Acute Myeloid Leukemia
100%
Adjuvant
5%
Apoptosis
61%
Bithionol
50%
Cell Death
12%
Chemotherapy
5%
Cisplatin
50%
Combination Therapy
56%
Cytotoxicity
7%
Diseases
12%
Drug
25%
Drug Screening
6%
Esophageal Adenocarcinoma
50%
Gemtuzumab
7%
Glimepiride
6%
Hematologic Malignancy
7%
Inhibitor of Apoptosis Protein
50%
Malignant Transformation
6%
Mitogen Activated Protein Kinase
6%
Nanoparticle
50%
Neuromuscular Blocking Agent
6%
Pancuronium Bromide
6%
Patient History of Chemotherapy
5%
Pharmacokinetics
7%
Phosphatase
6%
Polyglactin
14%
Protein
12%
Purvalanol A
7%
Purvalanol A
6%
Repurposing
6%
Sepantronium Bromide
11%
Side Effect
7%
Survival
12%
Synergism
6%
Targeted Drug Delivery
7%
Therapeutic Effect
7%
Venetoclax
9%
Vinblastine Sulfate
6%
Vinca Alkaloid
6%
Medicine and Dentistry
Acute Myeloid Leukemia
7%
Analysis
12%
Aptitude
6%
Biopsy
6%
Cells
7%
Chemotherapeutic Agent
21%
Clinical Management
6%
Combination Therapy
28%
Comprehension
7%
Differentiation
7%
Diseases
14%
Drug
21%
Esophageal Adenocarcinoma
50%
Formaldehyde
12%
Functional Genomics
6%
Gene Expression
6%
Gene Set Enrichment
6%
Glimepiride
7%
Glucose Transporter 1
50%
Health Care Cost
7%
Lymphovascular Invasion
6%
Malignant Neoplasm
6%
Malignant Transformation
7%
Marker
50%
Multivariate Analysis
6%
Neoadjuvant Chemotherapy
18%
Neuromuscular Blocking Agent
7%
Overall Survival
12%
Pancuronium Bromide
7%
Paraffin
12%
Patient
43%
Pediatric Acute Myeloid Leukemia
50%
Precursor
7%
Prognosis
50%
Screening
50%
Surgery
31%
Surgical Margin
18%
Targeted Therapy
7%
Therapeutic Procedure
14%
Vinblastine Sulfate
7%
Vinca Alkaloid
7%
